IP Library Patent Application 11793285
Patent Application
App. No. 11/793,285

Hdl Cholesterol Sensor

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/793,285
Abstract

A method for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, the method comprising reacting the sample with a PEG-ylated protein to selectively complex non-HDL lipoproteins in the sample with the PEG-ylated protein, or with a PEG-ylated enzyme capable of selective reaction with high density lipoproteins, and subsequently measuring the amount of cholesterol in the high density lipoproteins, for example using an electrochemical technique.

Claims (72)

1 . A method for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, said method comprising reacting the sample with (a) a PEG-ylated protein and subsequently measuring the amount of cholesterol in the high density lipoproteins.

2 . A method according to claim 1 , wherein the amount of cholesterol in the high density lipoproteins is measured by reacting the sample with (b) a cholesterol ester hydrolysing reagent and (c) cholesterol oxidase or cholesterol dehydrogenase and determining the amount of cholesterol which has reacted with the cholesterol oxidase or cholesterol dehydrogenase.

3 . A method according to claim 1 , wherein the sample is additionally reacted with (f) a surfactant.

4 . A method according to claim 1 , wherein the PEG-ylated protein is a PEG-ylated polyaminoacid, gelatine, lysozyme, lactalbumin or serum albumin.

5 . A method according to claim 4 , wherein the PEG-ylated protein is PEG-ylated bovine serum albumin.

6 . A method according to claim 1 , wherein the amount of cholesterol in the high density lipoproteins is measured by an electrochemical technique.

7 . A method according to claim 6 , wherein the method comprises reacting the sample with

(a) a PEG-ylated protein;

(b) a cholesterol ester hydrolysing reagent;

(c) cholesterol oxidase or cholesterol dehydrogenase;

(d) a coenzyme;

(g) a redox agent capable of being oxidised or reduced to form a product; and optionally

(h) a surfactant,

and electrochemically detecting the amount of product formed.

8 . An electrochemical method for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, said method comprising reacting the sample with

(b) a cholesterol ester hydrolysing reagent;

(c) cholesterol oxidase or cholesterol dehydrogenase;

(d) a coenzyme;

(e) a redox agent capable of being oxidised or reduced to form a product; and optionally

(f) a surfactant,

(h) a complexing reagent capable of forming a complex with low density and very low density lipoproteins; and/or

(i) a PEG-ylated protein;

and electrochemically detecting the amount of product formed, wherein the cholesterol ester hydrolysing reagent and/or cholesterol oxidase or cholesterol dehydrogenase is modified with polyethylene glycol.

9 . A method according to claim 8 , wherein the complexing agent (h) comprises a polyanion selected from phosphotungstic acid and salts thereof, dextran sulphuric acid and salts thereof, polyethylene glycol and heparin and salts thereof and optionally also comprises a divalent metal salt.

10 . A method according to claim 8 , wherein the complexing reagent (h) comprises an antibody capable of binding to apoB-containing lipoproteins.

11 . A method according to claim 8 , one of claims 8 to 10 , wherein the cholesterol ester hydrolysing reagent (b) is an optionally PEG-ylated cholesterol esterase or lipase.

12 . A method according to claim 11 wherein component (b) is an optionally PEG-ylated cholesterol esterase or lipase and component (c) is optionally PEG-ylated cholesterol dehydrogenase.

13 . A method according to claim 8 , wherein the sample is additionally reacted with (g) a reductase.

14 . (canceled)

15 . A method according to claim 8 , wherein the coenzyme (d) is NAD + or an analogue thereof.

16 . (canceled)

17 . A method according to claim 8 , wherein the sample is reacted simultaneously with the cholesterol ester hydrolysing reagent, cholesterol oxidase or cholesterol dehydrogenase and, if used, the PEG-ylated protein or complexing reagent.

18 . (canceled)

19 . A reagent mixture for use in a method for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, the reagent mixture comprising

(a) a PEG-ylated protein;

(b) a cholesterol ester hydrolysing reagent;

(c) cholesterol oxidase or cholesterol dehydrogenase; and optionally

(f) a surfactant.

20 . A reagent mixture according to claim 19 , which additionally comprises (d) a coenzyme, (e) a redox agent capable of being oxidised or reduced to form a product; and optionally (g) a reductase.

21 . A reagent mixture for use in an electrochemical method for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, the reagent mixture comprising

(b) a cholesterol ester hydrolysing reagent;

(c) cholesterol oxidase or cholesterol dehydrogenase;

(d) a coenzyme;

(e) a redox agent capable of being oxidised or reduced to form a product; and optionally

(h) a complexing reagent capable of forming a complex with low density and very low density lipoproteins; and/or

(i) a PEG-ylated protein;

wherein the cholesterol ester hydrolysing reagent and/or the cholesterol oxidase or cholesterol dehydrogenase is modified with polyethylene glycol.

22 . A reagent mixture according to claim 21 , which additionally comprises (f) a surfactant and/or (g) a reductase.

23 . A kit for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, the kit comprising (a) a PEG-ylated protein capable of selectively complexing with non-HDL lipoproteins, (b) a cholesterol ester hydrolysing reagent, (c) cholesterol oxidase or cholesterol dehydrogenase, optionally (f) a surfactant, and means for measuring the amount of cholesterol which reacts with the cholesterol oxidase or cholesterol dehydrogenase.

24 . A kit for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, the kit comprising

an electrochemical cell having a working electrode, a reference or pseudo reference electrode and optionally a separate counter electrode;

the reagents defined in claim;

a power supply for applying a potential across the cell; and

a measuring instrument for measuring the resulting electrochemical response.

25 . A kit according to claim 24 , wherein the reagents are present as a single reagent mixture.

26 . A kit according to claim 25 , wherein the reagent mixture is in dried form.

27 . A kit according to claim 24 , wherein the working electrode is a microelectrode having at least one dimension of less than 50 μm.

28 . A kit according to claim 24 , wherein the electrochemical cell is in the form of a receptacle or partial receptacle, the working electrode is in a wall of the receptacle or partial receptacle and the reagents are at least partly contained within the receptacle or partial receptacle.

29 . A kit according to claim 24 comprising a strip having at least one receptacle or partial receptacle formed therein, the receptacle or partial receptacle having a first open part in a first surface of the strip to enable a sample to enter the receptacle or partial receptacle,

wherein the working electrode of the electrochemical cell is in a wall of the receptacle or partial receptacle, and

wherein the reference or pseudo reference electrode of the electrochemical cell comprises a reference or pseudo reference electrode layer formed on at least a part of the first surface of the strip, and

wherein the reagents are at least partly contained within the receptacle or partial receptacle.

30 . A kit for the determination of the amount of cholesterol in high density lipoproteins in a high density lipoprotein containing sample, the kit comprising

an electrochemical cell having a working electrode, a reference or pseudo reference electrode and optionally a separate counter electrode;

the reagents defined in claim 21 ;

a power supply for applying a potential across the cell; and

a measuring instrument for measuring the resulting electrochemical response.

31 . A method of operating a kit as defined in claim 24 , said method comprising

(i) contacting (1) the reagents and (2) a high density lipoprotein containing sample, with each other and with the electrodes;

(ii) applying a potential across the electrochemical cell; and

(iii) electrochemically detecting the amount of product formed by measuring the resulting electrochemical response.

32 . (canceled)

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2011
From: F. HOFFMANN-LA ROCHE AG A/K/A F. HOFFMAN-LA ROCHE LTD; F. HOFFMANN-LA ROCHE LTD
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 026110/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2011
From: OXFORD BIOSENSORS LIMITED
To: F. HOFFMAN-LA ROCHE LTD A/K/A F. HOFFMANN-LA ROCHE AG AND HOFFMANN-LA ROCHE LTD
Reel/Frame 025993/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2007
From: ROBLIN, PATRICIA M.; BROUGHALL, JOHN M.; WONG, LUET L.
To: OXFORD BIOSENSORS LIMITED
Reel/Frame 019637/0110 →